Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131450) titled 'Clinical Efficacy of Teprotumumab in Elderly Patients (>=60 Years Old) with Thyroid Eye Disease: A Prospective Observational Registry Study' on Sept. 2.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: China National Nuclear Corporation 416 Hospital

Condition: Thyroid Eye Disease

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-11

Target Sample Size: Patients with thyroid eye disease aged >= 60 years:40;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=328971

Disclaimer: Curated by HT Syndicatio...